Literature DB >> 31359767

Three new acenaphthene derivatives from rhizomes of Musa basjoo and their cytotoxic activity.

Li Jiang1,2,3, Bao Zhang1,2,3, Yang Wang1,2,3, Jia Sun1,4, Xue Ma1,2, Guangcheng Wang1,4, Sihong Fu1,2,3, Changhu Lin1,2, YongJun Li1,2.   

Abstract

Three new acenaphthene derivatives cis-3-(4'-methoxyphenyl)-acenaphthene-1, 2-diol (1), trans-(1S, 2S)-3-phenyl-acenaphthene-1, 2-diol (2) and 8-(4-hydroxyphenyl)-2H-acenaphthylen-1-one (3) in company with six known compounds were isolated from the 70% ethanol extract of the rhizomes of Musa basjoo. Those chemical constituents were separated and purified by macroreticular resin, silica gel, Toyopearl HW-40F, SephadexLH-20 and other chromatographic methods, respectively. The chemical structures of new compounds were elucidated by HR-ESI-MS, 1H NMR, 13C NMR, HMQC, HMBC spectrum and specific optical rotations. Compound 4 was isolated for the first time from the genus Musa and compound 7 was firstly assigned the carbon spectrum. Furthermore, the cytotoxic activity of compounds 1-9 against WM9, MDA-MB231, HeLa, K562, DU145 and PC3 was screened with cisplatin as a positive control. Compound 9 showed promising cytotoxic activities with IC50 values of 2.65 ± 0.38 µM against the HeLa cell lines, while compound 8 possessed significant cytotoxicity with IC50 values of 6.51 ± 0.44, 18.54 ± 0.68 and 7.98 ± 1.44 µM against the HeLa, MDA-MB231 and WM9 cell lines, respectively.

Entities:  

Keywords:  Musa basjoo; Rhizomes; acenaphthene derivatives; cytotoxic activity; structure elucidation

Year:  2019        PMID: 31359767     DOI: 10.1080/14786419.2019.1647422

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  1 in total

1.  Extracts of Musa basjoo induce growth inhibition and changes in the protein expression of cell cycle control molecules in human colorectal cancer cell lines.

Authors:  Harutoshi Matsumoto; Saeko Ando; Eri Yoshimoto; Takamasa Numano; Nahida Sultana; Katsumi Fukamachi; Munekazu Iinuma; Kensuke Okuda; Kazunori Kimura; Masumi Suzui
Journal:  Oncol Lett       Date:  2022-01-27       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.